The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), and Eppendorf AG (Germany), KUBOTA Corporation (Japan), Sigma Laborzentrifugen GmbH (Germany), NuAire (US) Browse 426 market data Tables and 55 Figures spread through 373 Pages and in-depth TOC on “Laboratory Centrifuges Market by Product (Equipment(Microcentrifuge, Ultracentrifuge), Accessories(Tube, Plate)), Model(Benchtop), […]
Tag: Pharmaceuticals & Biotech
Global Dementia Drugs Market Size to grow at a CAGR of ~8% by 2030, Evaluates DelveInsight
Dementia Drugs Market Dementia drugs companies working in the market include Apotex Inc, AstraZeneca, Aurobindo Pharma, Eisai Co., Ltd, Eli Lilly and Company, Johnson and Johnson, Pfizer, Inc., Teva Pharmaceuticals, Zydus Cadila, Janssen Pharmaceuticals, Inc., Biogen Pharmaceuticals, Forest Laboratories, Inc., Novartis AG, Sanofi S.A., AstraZeneca, F. Hoffmann-La Roche, Merck and Co., Inc., and Valeant Pharmaceutical […]
Polycythemia Vera Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, and Clinical Trials | Roche, Fujifilm Holdings Corp, Hangzhou Bensheng Pharma, Protagonist Therapeutics, Ascentage
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polycythemia Vera pipeline constitutes 10+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the […]
B-Cell Non-Hodgkin Lymphoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
DelveInsight’s, “B-Cell Non-Hodgkin Lymphoma Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in B-Cell Non-Hodgkin Lymphoma pipeline landscape. It covers the B-Cell Non-Hodgkin Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the B-Cell Non-Hodgkin Lymphoma therapeutics assessment by product type, stage, route of administration, […]
Celiac Disease Clinical Trials 2024 (Updates): EMA, PDMA, FDA Approvals, Therapies, Treatment Market, ROA, MOA and Companies by DelveInsight
Celiac Disease Clinical Trials Celiac Disease companies are Chugai Pharmaceutical, Calypso Biotech, AMYRA Biotech AG, Equillium Bio, ImmunogenX, Amgen, and others. (Albany, United States) Celiac Disease pipeline constitutes 25+ key companies continuously working towards developing 25+ Celiac Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. […]
Sepsis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medications, Treatment Market, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight
Sepsis Clinical Trials Sepsis companies are Pharmazz, Shionogi, Octapharma, Seres Therapeutics, Matisse Pharmaceuticals, Inotrem, Beijing Scitech-Mq Pharmaceuticals, AdrenoMed AG, Shaperon, Recce Pharmaceuticals, Tianjin Chase Sun Pharmaceutical, SNIPR Biome, and others. (Albany, United States) Sepsis pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, […]
Acute On Chronic Liver Failure Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | RHEACELL, Versantis, Martin Pharmaceuticals, Grifols Therapeutics
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute On Chronic Liver Failure pipeline constitutes 8+ key companies continuously working towards developing 8+ Acute On Chronic Liver Failure treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acute On Chronic Liver Failure Pipeline report […]
Non-Cystic Fibrosis Bronchiectasis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi Farmaceutici, SolAeroMe
The Key Non-Cystic Fibrosis Bronchiectasis Companies in the market include – Boehringer Ingelheim, Zambon, Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others. DelveInsight’s “Non-Cystic Fibrosis Bronchiectasis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the […]
Dry Eye Disease Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Palatin Technologies, Novaliq, mc2 therapeutics
The Key Dry Eye Disease Companies in the market include – Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye […]
Atopic Dermatitis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharma, SCM Lifescience, Sun Pharma, Brickell Bio
The Key Atopic Dermatitis Companies in the market include – Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, […]